Head-to-head trial shows Eli Lilly’s oral GLP-1 orforglipron outperforms oral semaglutide
February 26, 2026 4 min read Add Us On GoogleAdd SciAm Head-to-head trial pitting Eli Lilly’s oral GLP-1 against oral semaglutide underscores efficacy of weight-loss pills A new trial found that Eli Lilly’s GLP-1 pill resulted in greater reductions in blood sugar levels and weight than oral semaglutide did, but fewer people stayed on it…
